InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: FI101 post# 35421

Thursday, 07/29/2021 11:18:17 AM

Thursday, July 29, 2021 11:18:17 AM

Post# of 35961
I know you didn't call it a scam but others have. By means of an October 2020 agreement Ridgeway Therapeutics (Dr. Colin Hislop CEO and President) took control of the company. He is a biotech veteran experienced in moving clinical stage drugs along. His day job is currently Senior V.P. at Eiger Biopharmaceuticals. Ridgeway had or has 65,000,000 million shares of NSPX. Hislop has incentive to make RT-AR001 a viable drug candidate. There may be more to come from NSPX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News